AMBULATE VASCADE MVP Same Day Discharge Retrospective Registry

CompletedOBSERVATIONAL
Enrollment

497

Participants

Timeline

Start Date

October 9, 2020

Primary Completion Date

January 11, 2021

Study Completion Date

February 8, 2021

Conditions
Atrial Fibrillation
Interventions
DEVICE

VASCADE MVP VVCS

The VASCADE MVP Venous Vascular Closure System (VVCS) is indicated for the percutaneous closure of femoral venous access sites while reducing time to ambulation, total post-procedure time, time to hemostasis, and time to discharge eligibility in patients who have undergone catheter-based procedures utilizing 6 - 12F inner diameter (maximum 15F OD) procedural sheaths, with single or multiple access sites in one or both limbs.

Trial Locations (4)

20010

MedStar Washington, Washington D.C.

44195

Cleveland Clinic, Cleveland

93401

Coastal Cardiology, San Luis Obispo

01805

Lahey Clinic, Burlington

Sponsors
All Listed Sponsors
lead

Cardiva Medical, Inc.

INDUSTRY